Prof. Dr. Didem TAŞTEKİN

Yayın Ağı

Makaleler 69

1. IGF Pathway Components as Potential Biomarkers in Gastric Cancer

CEYLANER B., ŞAHİN F., YILDIZ A., TAŞTEKİN D., GÖK A. F. K., BAYKAL A. T.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.22, 2025 (SCI-Expanded, Scopus)

2. A Pilot Study of Exploring miRNA-Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis.

Şen S., Özgel M. Ç., Tunçer Ş. B., Bozbey H. U., Karabulut S., Taştekin D.

Diagnostics (Basel, Switzerland) , cilt.15, sa.19, 2025 (SCI-Expanded)

3. Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model

Monfaredan A., Şen S., Fathi N. K., Taştekin D., Hosseininasab A., Bozbey H. U., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.17, 2025 (SCI-Expanded)

4. Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model

Monfaredan A., ŞEN S., Hosseininasab A., TAŞTEKİN D., Fazli G., Bozbey H. U., et al.

Cancers , cilt.17, sa.10, 2025 (SCI-Expanded, Scopus)

5. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study

DEMİRCİ N. S., AZİZY A., Paksoy N., Doǧan I., KARABULUT S., Karahan L., et al.

Medicine (United States) , cilt.103, sa.9, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer

KARABULUT S., ŞEN S., OĞUZ SOYDİNÇ H., Dogan I., TAŞTEKİN D., Karabulut M., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.254, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

7. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

KÖSTEK O., Demirel A., Hacıoğlu M. B., TAŞTEKİN D., KARABULUT S., Gündogdu A., et al.

Journal of Chemotherapy , cilt.36, sa.7, ss.613-621, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

8. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.

The oncologist , cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded)

9. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study

Senyurek S., Saglam S., Saglam E. K., Yanar H., Gok K., TAŞTEKİN D., et al.

ONCOLOGY RESEARCH , cilt.31, sa.5, ss.689-696, 2023 (SCI-Expanded)

10. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience

TAŞTEKİN D., Paksoy N., DOĞAN İ., Ferhatoglu F., KHANMAMMADOV N., Bozbey H. U., et al.

Journal of cancer research and therapeutics , cilt.19, sa.2, ss.253-258, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

11. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Erol C., Nahit Sendur M. A., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.

Journal of cancer research and therapeutics , cilt.18, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers

Karabulut S., Topalgokceli M. S., Tastekin D.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.6, sa.1, ss.12-15, 2022 (ESCI) Sürdürülebilir Kalkınma

13. Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma

Yalcinkaya B., Tastekin D., Guezelbulut F., Akgoz M., PENÇE S.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.68, sa.9, ss.1161-1165, 2022 (SCI-Expanded)

14. Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study

Paksoy N., Ferhatoglu F., DOĞAN İ., Khanmammadov N., Bozbey H. U., KARABULUT S., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, sa.4, ss.478-483, 2022 (ESCI)

15. Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study

Karabulut S., Dogan I., Usul Afsar C., Karabulut M., Karaman S., Ferhatoglu F., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.6, ss.1357-1363, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

16. WHAT'S NEW IN METASTATIC COLON CANCER TREATMENT?

Karabulut S., Karabulut M., Tastekin D.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.84, sa.3, ss.425-429, 2021 (ESCI) Sürdürülebilir Kalkınma

17. Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Dogan I., Tastekin D., Karabulut S., Sakar B.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded)

18. Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Yalcinkaya B., Guzel Tanoglu E., Tastekin D., Pence S.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.638-643, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Hacioglu M. B., Kostek O., Karabulut S., Tastekin D., SEZGİN GÖKSU S., Alandag C., et al.

JOURNAL OF BUON , cilt.25, sa.4, ss.1897-1903, 2020 (SCI-Expanded)

20. Investigation of JAM-A (rs790056) and LFA-1 (rs8058823) gene variants in Turkish colorectal cancer patients

Caykara B., Alsaadoni H., Pence H. H., Pence S., Aydogan H., Tastekin D.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.10, ss.872-876, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

21. The Association of Pancreatic Cancer and PALB2 Gene Mutations in the Turkish Population

Turkcan G. K., Odemis D., Avsar M., Tuncer S. B., Erciyas S., Erdogan Ö., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.34, sa.4, ss.283-290, 2019 (ESCI)

22. ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE

Bademler S., Ucuncu W. Z., Sari M., Yasasever C., Afsar C. U., Tastekin D.

ACTA MEDICA MEDITERRANEA , cilt.35, sa.1, ss.71-75, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Evaluation of JAM-A (rs790056) and LFA-1 (rs8058823) Variants in Colorectal Cancer

Caykara B., Alsaadoni H., PENÇE H. H., Pence S., Aydogan H., Tastekin D.

ACTA PHYSIOLOGICA , cilt.225, ss.25, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.

Gurdal N., Fayda M., ALISHEV N., Bakir B., Tastekin D., Aykan F., et al.

Tumori , cilt.104, ss.266-272, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, sa.3, ss.578-582, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., Tastekin D., Akyol M., et al.

CLINICAL COLORECTAL CANCER , cilt.16, sa.3, ss.220-227, 2017 (SCI-Expanded)

27. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., TAŞTEKİN D., Akyol M., et al.

JOURNAL OF BUON , cilt.21, sa.5, ss.1242-1249, 2016 (SCI-Expanded)

28. Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Kiziltan H. S., TAŞTEKİN D., ERİŞ A. H., Taspinar O., Ismaylova M., MAYADAĞLI A.

BEZMIALEM SCIENCE , cilt.4, sa.2, ss.51-55, 2016 (ESCI) Sürdürülebilir Kalkınma

29. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.

Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.

Journal of gastrointestinal cancer , cilt.47, ss.182-6, 2016 (Scopus) Sürdürülebilir Kalkınma

30. Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.5, ss.609-614, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

31. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome

Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.4, sa.4, ss.655-659, 2016 (ESCI) Sürdürülebilir Kalkınma

32. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients

Tas F., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.4, ss.489-492, 2016 (ESCI) Sürdürülebilir Kalkınma

33. Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.4, ss.485-488, 2016 (ESCI) Sürdürülebilir Kalkınma

34. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.

BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.27-29, 2016 (SCI-Expanded)

35. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.

BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.86-91, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. The relationship of beck depression inventory with vitamin D levels and visceral fat mass in cancer patients

Tuna S., Mert M., Soyluk O., Okuturlar Y., Kocoglu H., Tastekin D.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.5, ss.8719-8724, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

37. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.

TUMOR BIOLOGY , cilt.37, sa.1, ss.405-412, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer

Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.

European Review for Medical and Pharmacological Sciences , cilt.20, sa.2, ss.243-249, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

39. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment

Tezcan Y., Surmeli M., Tastekin D., Koc M.

ARCHIVES OF IRANIAN MEDICINE , cilt.18, sa.9, ss.606-607, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

40. Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.

Experimental oncology , cilt.37, ss.218-22, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

Turan N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.

CHINESE JOURNAL OF CANCER RESEARCH , cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded)

42. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.36, sa.3, ss.2097-103, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer

Arslan D., Tural D., Koca T., Tastekin D., Cerkesli A. K., Basaran H., et al.

JOURNAL OF BUON , cilt.20, sa.2, ss.573-579, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

44. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Biomedicine and Pharmacotherapy , cilt.69, ss.237-241, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

45. Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report

KIZILTAN H. Ş., GÜNEŞ BAYIR A., Taspinar O., Yucesan G., Tastekin D., Sonmez F. C., et al.

ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE , cilt.21, ss.68-72, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

46. The Effects of Topical Insulin Application on Wound Healing

Kargin S., Tastekin D., Kilic K., Cezik A., Cakir M., Kucukkartallar T., et al.

EUROPEAN JOURNAL OF GENERAL MEDICINE , cilt.12, sa.4, ss.302-306, 2015 (ESCI) Sürdürülebilir Kalkınma

47. Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients

Bal O., Arslan U. Y., Durnali A., Uyetrk U., Demirci A., Tastekin D., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.28-34, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

48. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation

Tatli A. M., Urakci Z., Kalender M. E., Arslan H., TAŞTEKİN D., Kaplan M. A.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.5, ss.2003-2007, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

49. The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity

Tastekin D., Tambas M., KILIC K., Erturk K., ARSLAN D.

INVESTIGATIONAL NEW DRUGS , cilt.32, sa.6, ss.1295-1300, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

50. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients

Tastekin D., Kargin S., KARABULUT M., Yaldiz N., Tambas M., Gurdal N., et al.

TUMOR BIOLOGY , cilt.35, sa.12, ss.11871-11877, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

51. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

MELANOMA RESEARCH , cilt.24, sa.5, ss.475-479, 2014 (SCI-Expanded)

52. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.9, ss.9303-9309, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

TURAN N., Benekli M., DANE F., Unal O. U., Kara H. V., KOCA D., et al.

Thoracic cancer , cilt.5, sa.5, ss.398-404, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

54. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY , cilt.35, sa.9, ss.8849-8860, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.

TUMOR BIOLOGY , cilt.35, sa.7, ss.6619-6625, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.

TUMOR BIOLOGY , cilt.35, sa.7, ss.6777-6782, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

57. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology

Uyeturk U., Oksuzoglu B., Akman T., Turker I., Sener N., Tastekin D., et al.

MEDICAL ONCOLOGY , cilt.31, sa.4, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Impact of Poster Presentations on Academic Knowledge Transfer from the Oncologist Perspective in Turkey

Arslan D., Koca T., Tastekin D., Basaran H., Bozcuk H.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.18, ss.7707-7711, 2014 (SCI-Expanded)

59. Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

KIZILTAN H. Ş., Bayir A. G., Tastekin D., ÇOBAN G., Eris A. H., AYDIN T., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.20, ss.8591-8594, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

60. Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age <= 35)

Goksu S. S., Tastekin D., Arslan D., Gunduz S., TATLI A. M., Unal D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.16, ss.6665-6668, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

61. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.18, sa.4, ss.273-278, 2014 (ESCI)

62. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.

TUMOR BIOLOGY , cilt.34, sa.6, ss.3529-3536, 2013 (SCI-Expanded)

63. Rectal cancer in pregnancy: a case report and review of the literature.

Dogan N., Tastekin D., Kerimoglu O., Pekin A., Celik C.

Journal of gastrointestinal cancer , cilt.44, ss.354-6, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology

Berk V., Kaplan M. A., Tonyali O., Buyukberber S., Balakan O., ÖZKAN M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.12, ss.7367-7369, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

65. The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

Hanci V., Kerimoğlu A., Koca K., Başkesen A., Kiliç K., Taştekin D.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES , cilt.16, ss.15-21, 2010 (SCI-Expanded)

66. [The opinions of Turkish physicians about the tasks of tuberculosis central dispensary].

Tanrikulu A., Palanci Y., Eren D., Yilmaz G., Karaca M., Abakay A., et al.

Tuberkuloz ve toraks , cilt.57, ss.32-7, 2009 (ESCI) Sürdürülebilir Kalkınma

67. Correlation between the erythrocyte sedimentation rate and blood nitric oxide levels in rabbits?

Uzun M., Saral S., Atakisi O., Yapar K., Uzlu E., Citil M., et al.

Scandinavian Journal of Laboratory Animal Science , cilt.35, sa.1, ss.53-56, 2008 (SCI-Expanded)

68. Investigation of free radical scavenging enzyme activities and lipid peroxidation in liver tissue of zinc deficient rats

Kaya H., Taysi S., Kaya A., Boyuk A., DURSUN H., Islamoglu Y., et al.

Asian Journal of Chemistry , cilt.20, sa.2, ss.1068-1074, 2008 (SCI-Expanded)

69. Hypoglycaemic effect of Artemisia herba-alba in experimental hyperglycaemic rats

Taştekin D., ATASEVER M., Adigüzel G., Keleş M., Taştekin A.

Bulletin of the Veterinary Institute in Pulawy , cilt.50, sa.2, ss.235-238, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 17

1. PANKREAS KANSERLİ HASTALARIN PERiFERİK KANINDA EPS8 VE KANK1 GEN EKSPRESYONLARININ İNCELENMESİ

ÖZGEL M. Ç., AKDENİZ ÖDEMİŞ D., TUNÇER Ş. B., TAŞTEKİN D., YAZICI H.

9. uluslararası beslenme obezite ve toplum sağlığı kongresi, 28 - 29 Ekim 2023, (Özet Bildiri)

2. Trastuzumab-based treatment of HER2-positive metastatic gastric cancer

Dogan I., Karabulut S., Tastekin D., Paksoy N., Sakar B., Vatansever S.

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31 Sürdürülebilir Kalkınma

3. The frequencies and prognostic significance of ABO blood and rhesus (D) groups in HER2-positive gastric cancer

Dogan I., Gurbuz M., Aydin E., Tastekin D., Karabulut S., Utkan G.

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Does nutritional status affect treatment tolarability, response, and survival in metastatic colorectal cancer patients? Results of prospective multicenter study

Karabulut S., Dogan I., Afsar C. U., Karabulut M., Karaman S., Ferhatoglu F., et al.

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.

3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

6. Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi

GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.

12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2016, ss.45, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. Nüks meme kanserinde reoperatif sentinel lenf nodu biyopsisi: Aksilla korunabilir mi?

Karanlık H., Özgür İ., Kılıç B., Şanlı Y., Önder S., Taştekin D., et al.

13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Türkiye, 21 - 25 Ekim 2015, ss.1, (Özet Bildiri) Sürdürülebilir Kalkınma

8. The role of adhesion molecules in hepatocellulary carcinoma

Tastekin D., DIKILITAS M., HARPUTLUOGLU H., Erturk K., CELEBI K., Sen F., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

9. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

Turan N., Araz M., Algin E., Unal O. U., Benekli M., Tastekin D., et al.

10. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

11. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) cud vascular cell adhesion molecule-1 (VCAM-1) levels in lung cancer.

KARABULUT S., Tastekin D., CIFTCI R., Tambas M., DAGOGLU N., Guveil M. E., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Clinical significance of serum caveolin-1 levels in melanoma.

Tastekin D., KARABULUT S., DURANYILDIZ D., Tas F.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

13. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Ciftci R., Karabulut S., Tastekin D., Sen F., Kilic L., Yildiz I., et al.

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)

14. The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

Cetin B., TAŞTEKİN D., Aktas B., Guler T., Kaplan M. A., Berk V., et al.

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)

15. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Turan N., Dane F., Unal O. U., Benekli M., Kara H. V., Koca D., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

Karabulut S., Kilic L., Ciftci R., Yildiz I., Sen F., Keskin S., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

Ciftci R., Keskin S., Karabulut S., Yildiz I., Kilic L., Sen F., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

Kitaplar 2

1. High-Dose Vitamin C Is an Unorthodox Approach to Cancer Treatment

Şen S., Ugar M., Bozbey H. U., Taştekin D.

Original Research and Reviews in the Field of Medical Oncology, selim güngör, Editör, Platanus Publishing, Ankara, ss.5-44, 2024

2. The Role of Extracellular Vesicles in Drug Resistance and Treatment of Metastatic Cancers

Şen S., Taştekin D.

Original Research and Reviews in the Field of Medical Oncology, Selim Güngör, Editör, Platanus Publishing, Ankara, ss.45-72, 2024

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

367

H-İndeks (WoS)

Atıf (Scopus)

575

H-İndeks (Scopus)

Atıf (Scholar)

404

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler